Monarch Capital Management Inc Eli Lilly & CO Transaction History

Monarch Capital Management Inc

$365 Million
Q3 2024

A detailed history of Monarch Capital Management Inc transactions in Eli Lilly & CO stock. As of the latest transaction made, Monarch Capital Management Inc holds 1,162 shares of LLY stock, worth $936,641. This represents 0.28% of its overall portfolio holdings.

Number of Shares

1,162

Previous 1,162 -0.0%

Holding current value

$936,641

Previous $1.05 Million 2.19%

% of portfolio

0.28%

Previous 0.31%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 24, 2024	BUY	$724.87 - $909.04 $19,571 - $24,544	27 Added 2.38%	1,162 $1.05 Million
Q1 2024 Apr 25, 2024	BUY	$592.2 - $792.28 $13,620 - $18,222	23 Added 2.07%	1,135 $882,000
Q4 2023 Jan 17, 2024	SELL	$525.19 - $619.13 $7,352 - $8,667	-14 Reduced 1.24%	1,112 $648,000
Q3 2023 Nov 02, 2023	SELL	$434.7 - $599.3 $21,735 - $29,964	-50 Reduced 4.25%	1,126 $604,000
Q1 2023 Apr 25, 2023	SELL	$310.63 - $364.82 $97,227 - $114,188	-313 Reduced 21.02%	1,176 $403,000
Q3 2022 Oct 20, 2022	SELL	$296.48 - $337.87 $11,859 - $13,514	-40 Reduced 2.62%	1,489 $481,000
Q2 2022 Jul 20, 2022	SELL	$278.73 - $327.27 $5,574 - $6,545	-20 Reduced 1.29%	1,529 $496,000
Q3 2021 Nov 04, 2021	SELL	$221.6 - $272.71 $28,808 - $35,452	-130 Reduced 7.74%	1,549 $358,000
Q1 2021 Apr 27, 2021	SELL	$164.32 - $212.72 $8,216 - $10,636	-50 Reduced 2.89%	1,679 $314,000
Q2 2020 Jul 23, 2020	SELL	$136.42 - $164.18 $88,127 - $106,060	-646 Reduced 27.2%	1,729 $284,000
Q1 2020 Apr 30, 2020	SELL	$119.05 - $147.35 $166,670 - $206,290	-1,400 Reduced 37.09%	2,375 $329,000
Q3 2019 Oct 30, 2019	SELL	$106.79 - $116.16 $10,679 - $11,616	-100 Reduced 2.58%	3,775 $422,000
Q2 2019 Jul 31, 2019	SELL	$110.79 - $129.32 $33,237 - $38,796	-300 Reduced 7.19%	3,875 $429,000
Q1 2019 May 01, 2019	SELL	$111.31 - $131.02 $60,997 - $71,798	-548 Reduced 11.6%	4,175 $542,000
Q3 2018 Nov 14, 2018	SELL	$85.86 - $107.31 $42,930 - $53,655	-500 Reduced 9.57%	4,723 $507,000
Q1 2018 Apr 18, 2018	BUY	$74.21 - $87.6 $11,131 - $13,140	150 Added 2.96%	5,223 $404,000
Q4 2017 Jan 31, 2018	SELL	$81.94 - $87.89 $49,164 - $52,734	-600 Reduced 10.58%	5,073 $428,000
Q3 2017 Oct 18, 2017	BUY	$77.07 - $85.54 $437,218 - $485,268	5,673	5,673 $485,000

Others Institutions Holding LLY

# of Institutions

3,918

Shares Held

765M

Call Options Held

6.34M

Put Options Held

7.96M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $766B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Monarch Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Monarch Capital Management Inc with notifications on news.

Account

Monarch Capital Management Inc Eli Lilly & CO Transaction History